Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Mechoulam

Showing results (171-180 of 183) with videos related to

Pageof 19
Sort By:
Plos One|August 26, 2016
Correction: Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic EffectsAviva Breuer, Christeene G Haj, Manoela V Fogaça, et al.
Psychopharmacology|June 20, 2020
Oleoyl alanine (HU595): a stable monomethylated oleoyl glycine interferes with acute naloxone precipitated morphine withdrawal in male ratsSamantha M Ayoub, Reem Smoum, Mathew Farag, et al.
Journal of Cellular Physiology|March 17, 2017
HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animalsJosef Večeřa, Eva Bártová, Jana Krejčí, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 23, 2018
Magel2 Modulates Bone Remodeling and Mass in Prader-Willi Syndrome by Affecting Oleoyl Serine Levels and ActivitySaja Baraghithy, Reem Smoum, Adi Drori, et al.
Frontiers in Pharmacology|October 4, 2021
Spontaneous and Naloxone-Precipitated Withdrawal Behaviors From Chronic Opiates are Accompanied by Changes in <i>N</i>-Oleoylglycine and <i>N</i>-Oleoylalanine Levels in the Brain and Ameliorated by Treatment With These MediatorsSamantha M Ayoub, Fabiana Piscitelli, Cristoforo Silvestri, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 25, 2015
Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in OsteoblastsNatalya M Kogan, Eitan Melamed, Elad Wasserman, et al.
Pharmacological Research|December 7, 2020
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed ratsMartina Di Bartolomeo, Tibor Stark, Oriana Maria Maurel, et al.
Neuropharmacology|March 24, 2018
N-Oleoyl-glycine reduces nicotine reward and withdrawal in miceGiulia Donvito, Fabiana Piscitelli, Pretal Muldoon, et al.
Neuropharmacology|November 30, 2018
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophreniaTibor Stark, Jana Ruda-Kucerova, Fabio Arturo Iannotti, et al.
Biochemical Pharmacology|May 4, 2020
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatmentTibor Stark, Martina Di Bartolomeo, Roberta Di Marco, et al.
Pageof 19

Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
Plos One|August 26, 2016
Correction: Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic EffectsAviva Breuer, Christeene G Haj, Manoela V Fogaça, et al.
Psychopharmacology|June 20, 2020
Oleoyl alanine (HU595): a stable monomethylated oleoyl glycine interferes with acute naloxone precipitated morphine withdrawal in male ratsSamantha M Ayoub, Reem Smoum, Mathew Farag, et al.
Journal of Cellular Physiology|March 17, 2017
HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animalsJosef Večeřa, Eva Bártová, Jana Krejčí, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 23, 2018
Magel2 Modulates Bone Remodeling and Mass in Prader-Willi Syndrome by Affecting Oleoyl Serine Levels and ActivitySaja Baraghithy, Reem Smoum, Adi Drori, et al.
Frontiers in Pharmacology|October 4, 2021
Spontaneous and Naloxone-Precipitated Withdrawal Behaviors From Chronic Opiates are Accompanied by Changes in <i>N</i>-Oleoylglycine and <i>N</i>-Oleoylalanine Levels in the Brain and Ameliorated by Treatment With These MediatorsSamantha M Ayoub, Fabiana Piscitelli, Cristoforo Silvestri, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 25, 2015
Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in OsteoblastsNatalya M Kogan, Eitan Melamed, Elad Wasserman, et al.
Pharmacological Research|December 7, 2020
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed ratsMartina Di Bartolomeo, Tibor Stark, Oriana Maria Maurel, et al.
Neuropharmacology|March 24, 2018
N-Oleoyl-glycine reduces nicotine reward and withdrawal in miceGiulia Donvito, Fabiana Piscitelli, Pretal Muldoon, et al.
Neuropharmacology|November 30, 2018
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophreniaTibor Stark, Jana Ruda-Kucerova, Fabio Arturo Iannotti, et al.
Biochemical Pharmacology|May 4, 2020
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatmentTibor Stark, Martina Di Bartolomeo, Roberta Di Marco, et al.
Pageof 19